Condition
Neoadjuvant clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Neoadjuvant clinical trials that are recruiting, at sites in 2 countries (most in China (5), United States (1)). By phase: Phase 2 (4), Phase 1/2 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 2Countries
Newest Neoadjuvant clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Ivonescimab with albumin‑paclitaxel and cisplatin before surgery for esophageal squamous cell carcinoma | Phase 1/2 | Xi'an, Shannxi | Recruiting | Feb 3, 2026 |
| Combining carboplatin with mirvetuximab soravtansine before surgery for FRα-positive advanced serous ovarian, fallopian tube, or primary peritoneal cancer | Phase 2 | Birmingham, Alabama and 72 other locations | Recruiting | Mar 24, 2025 |
| Neoadjuvant treatment for ER+/HER2+ breast cancer using a combination of drugs | Phase 2 | Wuhan, Hubei and 1 other locations | Recruiting | Aug 21, 2023 |
| Combining Axitinib and PD-1 to Improve Outcomes in Kidney Cancer | Phase 3 | Beijing and 7 other locations | Recruiting | Feb 22, 2023 |
| Combination therapy for high-risk acral melanoma before surgery | Phase 2 | Beijing, Beijing Municipality | Recruiting | Aug 23, 2022 |
| Using Imatinib Mesylate before surgery for gastrointestinal stromal tumors | Phase 2 | Hangzhou, Zhejiang | Recruiting | Jun 22, 2021 |
All recruiting trials (6)
-
Ivonescimab with albumin‑paclitaxel and cisplatin before surgery for esophageal squamous cell carcinoma
This trial tests whether adding ivonescimab to albumin‑paclitaxel and cisplatin before surgery helps people with resectable, locally advanced esophageal squamous cell carcinoma.
-
Combining carboplatin with mirvetuximab soravtansine before surgery for FRα-positive advanced serous ovarian, fallopian tube, or primary peritoneal cancer
This will test whether giving mirvetuximab soravtansine with carboplatin before surgery helps people with newly diagnosed FRα-positive advanced-stage serous ovarian, fallopian tube, or primary peritoneal cancer.
-
Neoadjuvant treatment for ER+/HER2+ breast cancer using a combination of drugs
This study is testing a new combination of drugs to see if it helps women with early or locally advanced HER2-positive breast cancer shrink their tumors before surgery.
-
Combining Axitinib and PD-1 to Improve Outcomes in Kidney Cancer
This study is testing if a combination of axitinib and PD-1 therapy can help kidney cancer patients who are at high risk of their cancer coming back after surgery.
-
Combination therapy for high-risk acral melanoma before surgery
This study is testing a new combination of treatments before surgery to see if it can help people with high-risk acral melanoma have better outcomes.
-
Using Imatinib Mesylate before surgery for gastrointestinal stromal tumors
This study is testing if taking imatinib mesylate before surgery can help people with high-risk gastrointestinal stromal tumors have better outcomes and live longer.
Related topics
Quick answers
How many Neoadjuvant clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (5 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 1/2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.